Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mild Cognitive Impairment Community Screening, Early Detection, and Therapeutic Intervention to Slow Down, or Stop the Progression of the Cognitive Impairment.

NCT07214974 is registered in ClinicalTrials.gov with Noah Tech, Corp. as lead sponsor.

NCT NCT07214974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07214974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mild Cognitive Impairment Community Screening, Early Detection, and Therapeutic Intervention to Slow Down, or Stop the Progression of the Cognitive Impairment.
Lead sponsor
Noah Tech, Corp.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
January 3, 2030
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease and related dementias, alzheimer's disease dementia, alzheimer's disease diagnosis, dementia (diagnosis), dementia mci (mild cognitive impairment), early stages of cognitive decline, mild cognitive impairment (mci), parkinson's disease, parkinson's disease (pd), parkinson's disease with wearing-off motor fluctuations